Abstract

Objective To investigate the impact of kallidinogenase on renal function in early diabetic kidney dis-ease. Methods Forty - six cases of patients suffered from type 2 diabetes mellitus were divided into two groups at random in which 26 cases served as observed group accepted kallidinogenasemedicationadditionally and the other 20 cases received comprehensive medication simultaneously. Fasting blood glucose, 2 hours postprandial blood glucose, glycosylated serum protein, total cholesterol, triglycerides, blood pressure, items of hemurheology, 24 - hour urine protein, time span of peak time, residual rate for 10 minutes and 15 minutes were record and compared before and after three cases of medication. Re-sults Indexes of hemorheoiogy decreased significantly after 3 causes of medication (P < 0. 01), blood lipid, and blood pressure also declined significantly(P <0.01). 15 minutes residual rate decreased significantly and I0 minutes residual rate also declined(P < 0. 01). The 24 - hour urinary protein reduced significantly(P < 0.01). Conclusions Kallidino-genase can effectively decrease blood viscosity and platelet aggregation, lowering blood lipids and blood pressure, improving the secretion and excretion function, reducing the discharge of urine protein and promote the resumption of diabetic kidney disease in early stage. Key words: Renal function; Kallidinogenase; Diabetes mellitus; Early diabetic kidney disease

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.